Cargando…
Metabolic Syndrome Ameliorated by 4-Methylesculetin by Reducing Hepatic Lipid Accumulation
Obesity is a chronic metabolic disease caused by an imbalance between energy intake and expenditure during a long period and is characterized by adipose tissue disfunction and hepatic steatosis. The aim of this study was to investigate the effect of 4-methylesculetin (4-ME), a coumarin derivative, u...
Autores principales: | Li, Linghuan, Zhu, Guangyao, Fu, Gaohang, Zha, Weiwei, Li, Hanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499566/ https://www.ncbi.nlm.nih.gov/pubmed/36142378 http://dx.doi.org/10.3390/ijms231810465 |
Ejemplares similares
-
4-Methylesculetin ameliorates LPS-induced depression-like behavior through the inhibition of NLRP3 inflammasome
por: Choudhary, Khushboo, et al.
Publicado: (2023) -
Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism
por: Yeh, Yu-Te, et al.
Publicado: (2018) -
Scolymus hispanicus (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty Diet
por: Berdja, Sihem, et al.
Publicado: (2021) -
Sulforaphane ameliorates bisphenol A-induced hepatic lipid accumulation by inhibiting endoplasmic reticulum stress
por: Hong, Lixia, et al.
Publicado: (2023) -
Ginseng seed oil ameliorates hepatic lipid accumulation in vitro and in vivo
por: Kim, Go Woon, et al.
Publicado: (2018)